Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rh-PDGF Versus Emdogain for Treatment of Intra-bony Defects
NCT05442034Phase 2Recruiting
- Sponsor
- Nova Southeastern University
- Start
- Jan 2023
- Primary completion
- Jun 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of becaplermin in intrabony periodontal defect, sponsored by Nova Southeastern University. Started Jan 2023; status: recruiting.
02
Drugs
becaplermin
03
Conditions
intrabony periodontal defect
Beyond the preview
Go deeper on NCT05442034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05442034.